Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 20, 2012European Respiratory Journal

Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB

View Full Paper
Ask AI
Bookmark
Share

Authors

SLSaverio De LorenzoFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoJAJ. W. C. AlffenaarResearch Center Borstel - Leibniz Lung CenterGSGiovanni SotgiuUniversity of Sassari

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lorenzo et al. (2012) studied this question.

synapsesocial.com/papers/6a8aa50caf6b08ee8d72489fhttps://doi.org/10.1183/09031936.00124312
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Delamanid for Multidrug-Resistant Pulmonary Tuberculosis2012 · 747 citations
  2. 2Prof. Brian James Whipp, 1937–2011: a master in respiratory and exercise physiology: Figure 12011 · 4 citations
  3. 3Irreversible Inhibition of the Mycobacterium tuberculosis β-Lactamase by Clavulanate2007 · 224 citations